# China NMPA Drug Inspection - Sichuan Wanglintang Pharmaceutical Co., Ltd. - Huoxiang Zhengqi Capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sichuan-wanglintang-pharmaceutical-co-ltd/36f37a40-6999-482a-9b37-b06b35f2d1ec/
Source feed: China

> China NMPA drug inspection for Sichuan Wanglintang Pharmaceutical Co., Ltd. published March 20, 2020. Drug: Huoxiang Zhengqi Capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Gansu Provincial Drug Administration Regarding Sampling Inspection Information of Drugs Used for COVID-19 Prevention and Control
- Company Name: Sichuan Wanglintang Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-20
- Drug Name: Huoxiang Zhengqi Capsules
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/sichuan-wanglintang-pharmaceutical-co-ltd/b820b510-3f0e-4686-bfa4-b5e00b3d0e3d/